Cargando…

Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer

OBJECTIVE: Resistance of metastatic lymph nodes (LNs) to high dose I-131 therapy is associated with high morbidity in patients with differentiated thyroid cancer. We evaluated the role of F-18 FDG PET/CT in the prediction of resistance to high dose I-131 therapy in patients with papillary thyroid ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byun, Byung Hyun, Kwon, Seong Young, Chong, Ari, Kim, Jahae, Yoo, Su Woong, Min, Jung-Joon, Song, Ho-Chun, Bom, Henry Hee-Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia Oceania Journal of Nuclear Medicine & Biology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937673/ https://www.ncbi.nlm.nih.gov/pubmed/27408836 http://dx.doi.org/10.7508/aojnmb.2013.01.003

Ejemplares similares

Transient (18)FDG-avid hilar lymph node on PET/CT imaging in asymptomatic COVID-19
por: Karimi-Galougahi, Mahboobeh, et al.
Publicado: (2020)

Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy
por: Cho, Sang-Geon, et al.
Publicado: (2019)

Thyroidectomy and Lymph Node Dissection in Papillary Thyroid Carcinoma
por: Ito, Yasuhiro, et al.
Publicado: (2010)

(18)F-FDG–Avid Axillary Lymph Nodes After COVID-19 Vaccination
por: Johnson, B. Jake, et al.
Publicado: (2021)

Avid (18)F-FDG Uptake in Idiopathic Tumoral Calcinosis Mimicking Lymph Node Metastasis
por: Strandberg, Jesper, et al.
Publicado: (2017)

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer
por: Lee, Chang-Hee, et al.
Publicado: (2018)

AN UNUSUAL CASE OF PAPILLARY THYROID CARCINOMA IODINE-131 AVID METASTASIS TO THE ADRENAL GLAND
por: Blažeković, Ivan, et al.
Publicado: (2018)

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
por: Xing, Zhichao, et al.
Publicado: (2021)

Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study
por: Laasik, Maren, et al.
Publicado: (2019)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
por: Reinholdt, Kasper Basse, et al.
Publicado: (2022)

A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [(18)F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer
por: Piao, Hong Hua, et al.
Publicado: (2021)

Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
por: Jiang, Yongji, et al.
Publicado: (2023)

Predicting (131)I-avidity of metastases from differentiated thyroid cancer using (18)F-FDG PET/CT in postoperative patients with elevated thyroglobulin
por: Liu, Min, et al.
Publicado: (2018)

Performance of Ultrasound-Guided Core Biopsy Driven by FDG-avid Supraclavicular Lymph Nodes in Patients With Suspected Lung Cancer
por: Wang, Tongtong, et al.
Publicado: (2022)

FDG-avid antrum-pylorus ulcer, adjacent lymph node, and abdominal wall nodule mimicking gastric cancer with metastases
por: Ruan, Dan, et al.
Publicado: (2022)

Intra-operative use of PET probe for localization of FDG avid lesions
por: Molina, M.A., et al.
Publicado: (2009)

FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023)

(11)C-Choline-Avid but (18)F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography
por: Kitajima, Kazuhiro, et al.
Publicado: (2016)

Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation
por: Garcia, Brandon, et al.
Publicado: (2016)

Evaluation of Mediastinal Lymph Nodes in Sarcoidosis, Sarcoid Reaction, and Malignant Lymph Nodes Using CT and FDG-PET/CT
por: Koo, Hyun Jung, et al.
Publicado: (2015)

Completion Total Thyroidectomy Is Not Necessary for Papillary Thyroid Microcarcinoma with Occult Central Lymph Node Metastasis: A Long-Term Serial Follow-Up
por: Choi, Soon Min, et al.
Publicado: (2020)

Covid-19-vaccine/mrna-1273: (18)F-FDG avidity in the lymph nodes and injection site soreness: 2 case reports
Publicado: (2022)

FDG-PET staging and importance of lymph node SUV in head and neck cancer
por: Kubicek, Gregory J, et al.
Publicado: (2010)

(18)F-FDG PET–CT Diagnosis of Tuberculosis in Celiac Lymph Nodes
por: Mao, Xi Bao, et al.
Publicado: (2020)

FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT
por: Nguyen, Xuan Canh, et al.
Publicado: (2015)

Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity
por: Doherty, Leana, et al.
Publicado: (2017)

Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT
por: Chong, Ari, et al.
Publicado: (2017)

Renal Metastasis and Dual ((18)F-Fluorodeoxyglucose and (131)I) Avid Skeletal Metastasis in a Patient with Papillary Thyroid Cancer
por: Kulkarni, Prashanth, et al.
Publicado: (2017)

Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity
por: Wang, Yingbing, et al.
Publicado: (2013)

Spectrum of [(18)F]FDG-PET/CT Findings in Benign Lymph Node Pathology
por: Zeman, Merissa N., et al.
Publicado: (2021)

Clinical effect of Lymph Node Dissection in the Lateral Neck for the treatment of Papillary Thyroid Carcinoma: Endoscopic Thyroidectomy versus Open Surgery
por: Wang, Guangyu, et al.
Publicado: (2023)

Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on (18)F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma
por: Jung, Ji-hoon, et al.
Publicado: (2015)

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma
por: Lee, Hyunjong, et al.
Publicado: (2022)

Predictive value of LN metastasis detected by (18)F-FDG PET/CT in patients with papillary thyroid cancer receiving iodine-131 radiotherapy
por: Li, Chao, et al.
Publicado: (2019)

A retrospective observational study of benign anthracotic lymphadenitis and its association with PET avid lymph nodes in patients undergoing cancer evaluation
por: Ivanick, Nathaniel M., et al.
Publicado: (2021)

(18)F-Fluciclovine–Avid Axillary Lymph Nodes After COVID-19 Vaccination on PET/CT for Suspected Recurrence of Prostate Cancer
por: Peacock, Justin G., et al.
Publicado: (2022)

A Retrospective Study of predicting risk of Metastasis among FDG-avid Bone Lesions in (18)F-FDG PET/CT
por: Yao, Guangyu, et al.
Publicado: (2020)

FDG avid pulmonary amyloid nodule in a patient with metastatic renal cell cancer on 18F-FDG PET/CT
por: Lee, Marco Enoch, et al.
Publicado: (2021)

Predictive Value of [(18)F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
por: Kim, Sung Hoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t20555cp5jo9kmncb4ijtrpjkk